Testing new ground

  title={Testing new ground},
  author={Hannah Hoag},
  journal={Nature Biotechnology},
the tests that followed in the 1980s and early 1990s targeted infectious diseases, and tests for HIV, hepatitis C and human papilloma virus (HPV) remain in strong demand today. Lately, molecular tests that diagnose and predict cancers have become more profitable targets. Cardiovascular disease has become another popular target as rates of heart disease… CONTINUE READING